glp-1 small molecule agonist A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency A potent novel small molecule

Lab Tested: Each batch is verified via HPLC and mass spectrometry

Although description of gonorrhea-like symptoms dates back to ancient civilizations like the Romans, Jews, and Arabs, genomic analysis suggests that the modern gonococcal population originated much more recently, possibly in the 16 th century, and was subsequently spread globally (Golparian et al., 2020)

The SURMOUNT-1 study was a placebo-controlled 72-week trial in obese subjects that randomized 2,539 participants without diabetes into four equally large study arms with placebo or one of the three tirzepatide doses (5, 10, or 15 mg once weekly)

The cosmetic industry is, of course, really trying to solve this problem and the best solution so far is using nanoparticles